(Q45785271)

16 December 2017

title

Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotype (English)

1 reference

16 December 2017

0 references

1 reference

vertical transmission

1 reference

Husson RN

1

1 reference

16 December 2017

Lan Y

2

1 reference

16 December 2017

Kojima E

3

1 reference

16 December 2017

Venzon D

4

1 reference

16 December 2017

Mitsuya H

5

1 reference

16 December 2017

McIntosh K

6

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

16 December 2017

The Journal of Pediatrics

published in

1 reference

16 December 2017

volume

126

1 reference

16 December 2017

page(s)

865-871

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Perinatal Transmission of the Human Immunodeficiency Virus Type 1 to Infants of Seropositive Women in Zaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Maternal predictors of perinatal human immunodeficiency virus transmission. The New York City Perinatal HIV Transmission Collaborative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Features of HIV-1 that could influence maternal-child transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

Risk factors for mother-to-child transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970198-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(95)70198-2

1 reference

16 December 2017

PubMed ID

7776085

1 reference

16 December 2017